These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 37207298)

  • 21. In Silico Prediction of Chemically Induced Mutagenicity: How to Use QSAR Models and Interpret Their Results.
    Mombelli E; Raitano G; Benfenati E
    Methods Mol Biol; 2016; 1425():87-105. PubMed ID: 27311463
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of QSAR models for predicting mutagenicity: outcome of the Second Ames/QSAR international challenge project.
    Furuhama A; Kitazawa A; Yao J; Matos Dos Santos CE; Rathman J; Yang C; Ribeiro JV; Cross K; Myatt G; Raitano G; Benfenati E; Jeliazkova N; Saiakhov R; Chakravarti S; Foster RS; Bossa C; Battistelli CL; Benigni R; Sawada T; Wasada H; Hashimoto T; Wu M; Barzilay R; Daga PR; Clark RD; Mestres J; Montero A; Gregori-Puigjané E; Petkov P; Ivanova H; Mekenyan O; Matthews S; Guan D; Spicer J; Lui R; Uesawa Y; Kurosaki K; Matsuzaka Y; Sasaki S; Cronin MTD; Belfield SJ; Firman JW; Spînu N; Qiu M; Keca JM; Gini G; Li T; Tong W; Hong H; Liu Z; Igarashi Y; Yamada H; Sugiyama KI; Honma M
    SAR QSAR Environ Res; 2023; 34(12):983-1001. PubMed ID: 38047445
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Topological structural alerts modulations of mammalian cell mutagenicity for halogenated derivatives.
    Pérez-Garrido A; Girón-Rodríguez F; Morales Helguera A; Borges F; Combes RD
    SAR QSAR Environ Res; 2014; 25(1):17-33. PubMed ID: 24283490
    [TBL] [Abstract][Full Text] [Related]  

  • 24. QSAR models to predict mutagenicity of acrylates, methacrylates and alpha,beta-unsaturated carbonyl compounds.
    Pérez-Garrido A; Helguera AM; Rodríguez FG; Cordeiro MN
    Dent Mater; 2010 May; 26(5):397-415. PubMed ID: 20122717
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In Silico Prediction of Chemically Induced Mutagenicity: A Weight of Evidence Approach Integrating Information from QSAR Models and Read-Across Predictions.
    Mombelli E; Raitano G; Benfenati E
    Methods Mol Biol; 2022; 2425():149-183. PubMed ID: 35188632
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative evaluation of 11 in silico models for the prediction of small molecule mutagenicity: role of steric hindrance and electron-withdrawing groups.
    Ford KA; Ryslik G; Chan BK; Lewin-Koh SC; Almeida D; Stokes M; Gomez SR
    Toxicol Mech Methods; 2017 Jan; 27(1):24-35. PubMed ID: 27813437
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In Silico Approaches in Predictive Genetic Toxicology.
    Sinha M; Dhawan A; Parthasarathi R
    Methods Mol Biol; 2019; 2031():351-373. PubMed ID: 31473971
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Towards quantitative read across: Prediction of Ames mutagenicity in a large database.
    Benigni R
    Regul Toxicol Pharmacol; 2019 Nov; 108():104434. PubMed ID: 31374229
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of Nontoxic Substructures: A New Strategy to Avoid Potential Toxicity Risk.
    Yang H; Sun L; Li W; Liu G; Tang Y
    Toxicol Sci; 2018 Oct; 165(2):396-407. PubMed ID: 29893961
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A compilation of safety impact information for extractables associated with materials used in pharmaceutical packaging, delivery, administration, and manufacturing systems.
    Jenke D; Carlson T
    PDA J Pharm Sci Technol; 2014; 68(5):407-55. PubMed ID: 25336416
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In silico assessment of genotoxicity. Combinations of sensitive structural alerts minimize false negative predictions for all genotoxicity endpoints and can single out chemicals for which experimentation can be avoided.
    Benigni R
    Regul Toxicol Pharmacol; 2021 Nov; 126():105042. PubMed ID: 34506881
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of in silico models for prediction of mutagenicity.
    Bakhtyari NG; Raitano G; Benfenati E; Martin T; Young D
    J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2013; 31(1):45-66. PubMed ID: 23534394
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extending (Q)SARs to incorporate proprietary knowledge for regulatory purposes: A case study using aromatic amine mutagenicity.
    Ahlberg E; Amberg A; Beilke LD; Bower D; Cross KP; Custer L; Ford KA; Van Gompel J; Harvey J; Honma M; Jolly R; Joossens E; Kemper RA; Kenyon M; Kruhlak N; Kuhnke L; Leavitt P; Naven R; Neilan C; Quigley DP; Shuey D; Spirkl HP; Stavitskaya L; Teasdale A; White A; Wichard J; Zwickl C; Myatt GJ
    Regul Toxicol Pharmacol; 2016 Jun; 77():1-12. PubMed ID: 26879463
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of in silico systems and expert knowledge for structure-based assessment of potentially mutagenic impurities.
    Sutter A; Amberg A; Boyer S; Brigo A; Contrera JF; Custer LL; Dobo KL; Gervais V; Glowienke S; van Gompel J; Greene N; Muster W; Nicolette J; Reddy MV; Thybaud V; Vock E; White AT; Müller L
    Regul Toxicol Pharmacol; 2013 Oct; 67(1):39-52. PubMed ID: 23669331
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of the sensitivity of the computational programs DEREK, TOPKAT, and MCASE in the prediction of the genotoxicity of pharmaceutical molecules.
    Snyder RD; Pearl GS; Mandakas G; Choy WN; Goodsaid F; Rosenblum IY
    Environ Mol Mutagen; 2004; 43(3):143-58. PubMed ID: 15065202
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization and validation of an in silico toxicology model to predict the mutagenic potential of drug impurities.
    Valerio LG; Cross KP
    Toxicol Appl Pharmacol; 2012 May; 260(3):209-21. PubMed ID: 22426359
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identifying the structural requirements for chromosomal aberration by incorporating molecular flexibility and metabolic activation of chemicals.
    Mekenyan O; Todorov M; Serafimova R; Stoeva S; Aptula A; Finking R; Jacob E
    Chem Res Toxicol; 2007 Dec; 20(12):1927-41. PubMed ID: 18052113
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Merging applicability domains for in silico assessment of chemical mutagenicity.
    Liu R; Wallqvist A
    J Chem Inf Model; 2014 Mar; 54(3):793-800. PubMed ID: 24494696
    [TBL] [Abstract][Full Text] [Related]  

  • 39. QSAR modeling without descriptors using graph convolutional neural networks: the case of mutagenicity prediction.
    Hung C; Gini G
    Mol Divers; 2021 Aug; 25(3):1283-1299. PubMed ID: 34146224
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutagenicity, anticancer activity and blood brain barrier: similarity and dissimilarity of molecular alerts.
    Toropov AA; Toropova AP; Benfenati E; Salmona M
    Toxicol Mech Methods; 2018 Jun; 28(5):321-327. PubMed ID: 29281931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.